💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Athersys, Inc. (ATHX)
« Back to company indexATHX Chatter Timeline
Stock Ticker for ATHX
Most Active Tweeters for ATHX
| User | Tweets |
|---|---|
| @eastvillagetwt | 19 |
| @Tickeron | 9 |
| @TraderOfStocks1 | 7 |
| @Gambiste1 | 6 |
| @3Stocksaday | 6 |
Recent Tweets for ATHX
 |
@ATHXLover $athx together we can rule as one! https://t.co/v5tRH11KnY December 3rd 2021, 11:12pm |
 |
@TradeWithAlerts A nice print for $ATHX at 5:32pm -- SIDE: Ask Click https://t.co/OvaUxJ1s2y for more. Runners ?:… https://t.co/0BPdsTxvHC December 3rd 2021, 10:12pm |
 |
@Ba4Saso $ATHX Waiting for Short signal on athx with https://t.co/DFtBhic4Wk https://t.co/5lMpiaIfD8 December 3rd 2021, 6:12pm |
 |
@Tickeron $ATHX in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/GPuQy17AvH December 3rd 2021, 2:12pm |
 |
@DonnaSitnik RT @3crescentmoons: @HardyTSKagimoto Great! Have you applied for ARDS approval w/ the PMDA yet? Have you purchased $ATHX stock at these dep… December 3rd 2021, 1:12pm |
 |
@87_boogie @Biohazard3737 Data from $ATHX Japanese partner which could be the first major breakthrough for treatment of Ischem… https://t.co/8F4AhxV1oM December 3rd 2021, 3:12am |
|
@Tickeron $ATHX enters a Downtrend as Momentum Indicator dropped below the 0 level on November 12, 2021. View odds for this a… https://t.co/BreEs3OtIJ December 3rd 2021, 1:12am |
 |
@3crescentmoons @HardyTSKagimoto Great! Have you applied for ARDS approval w/ the PMDA yet? Have you purchased $ATHX stock at these… https://t.co/jC0TfJT9jB December 2nd 2021, 10:12pm |
 |
@Gambiste1 RT @CallMeK3X: $ATHX December 1c for 20 cents while it’s at 1.1 don’t mind if I do December 2nd 2021, 8:12pm |
 |
@CallMeK3X $ATHX December 1c for 20 cents while it’s at 1.1 don’t mind if I do December 2nd 2021, 8:12pm |
 |
@TradeOnTheWire1 $ATHX just like $ARDX December 2nd 2021, 6:12pm |
 |
@3Stocksaday $ATHX DEC $1 CALLS CHEAP ???? December 2nd 2021, 5:12pm |
|
@3Stocksaday $ATHX HOD LET’s break $1.10 ??? December 2nd 2021, 4:12pm |
|
@3Stocksaday $ATHX SHOUOD BE AN EASY 50% from here ??? December 2nd 2021, 4:12pm |
|
@3Stocksaday $ATHX LET’S BREAK $1.10 December 2nd 2021, 4:12pm |
|
@3Stocksaday $athx will make a move soon December 2nd 2021, 3:12pm |
 |
@TraderOfStocks1 $ATHX https://t.co/RxMoC7r5D2 December 2nd 2021, 2:12pm |
 |
@FlashAlert_me $ATHX [15s. delayed]: Issued Press Release on November 30, 06:00:00: Report of Placebo-Controlled Clinical Trial Ev… https://t.co/msGyRdCbWs December 2nd 2021, 7:12am |
|
@Tickeron How do you think the market will react to this? $ATHX The volume increased for one day, resulting in a record-break… https://t.co/xbzbhIzbqP December 1st 2021, 11:12pm |
 |
@askwarrenbuffet $ATHX CEO TO Detail Significant Partnership Agreement With Leading US Company As Early As Monday… https://t.co/C1CBAV5OoG December 1st 2021, 1:12am |
 |
@StockHorizon Want to subscribe? Start your subscription today with promo code NEWSUBDEAL! Latest top alert movers: $AHPI $ATHX… https://t.co/wy5Hiu3IrK November 30th 2021, 10:11pm |
|
@CallMeK3X $ATHX call are SL cheap ????? November 30th 2021, 8:11pm |
 |
@BrookerDon @Maximus_Holla Check out $ATHX. It could go with positive ARDS data that’s due any day! November 30th 2021, 8:11pm |
 |
@StockNewsNow $ATHX Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress… https://t.co/hInHxORteS November 30th 2021, 7:11pm |
 |
@IOInvestors Athersys $ATHX Stock Surges After ARDS Trial Results Published In Major Journal https://t.co/M0cfANslCT November 30th 2021, 5:11pm |
 |
@vipul0092003 $ATHX This gave 1.78+ in premarket today.... unfortunately didn’t had sell order placed... ? https://t.co/CV8Icf84RU November 30th 2021, 4:11pm |
 |
@eastvillagetwt RT @MarketCurrents: $ATHX - Athersys gains on publication of cell therapy study results against respiratory disorder https://t.co/S9RrcBqhcv November 30th 2021, 3:11pm |
|
@eastvillagetwt RT @petesart: $ATHX Athersys $ATHX Excellent ARDS clinical trial news. • with no allergic or serious adverse reactions associated with th… November 30th 2021, 3:11pm |
|
@eastvillagetwt $ATHX: Athersys, Inc. - Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute R… https://t.co/F2YZB3LRHC November 30th 2021, 3:11pm |
 |
@mtanfld @Pharmdca $ATHX? November 30th 2021, 3:11pm |
 |
@newsfilterio Athersys Shares Jump After MultiStem Cell Therapy Data Published In Medical Journal $ATHX https://t.co/YSLyUxcpUq November 30th 2021, 3:11pm |
|
@CallMeK3X $ATHX loading zone. ??? November 30th 2021, 3:11pm |
|
@Tickeron $ATHX enters a Downtrend as Momentum Indicator dropped below the 0 level on November 12, 2021. View odds for this a… https://t.co/K8Esk7YQk1 November 30th 2021, 2:11pm |
 |
@TopStockAlerts1 $ATHX ? November 30th 2021, 2:11pm |
|
@CallMeK3X RT @3Stocksaday: $athx Dec calls are cheap...! November 30th 2021, 2:11pm |
|
@3Stocksaday $athx Dec calls are cheap...! November 30th 2021, 2:11pm |
 |
@MarcJacksonLA $ATHX Athersys Reports Publication of Data from Placebo-Controlled Clinical Trial Evaluating MultiStem Cell Therapy… https://t.co/qZ7Ov89qmO November 30th 2021, 2:11pm |
|
@MarcJacksonLA $ATHX Athersys Sees Positive Data in Trial for Acute Respiratory Distress Syndrome Treatment https://t.co/OOX3kDFCSR November 30th 2021, 2:11pm |
 |
@OpenOutcrier $ATHX (+12.7% pre) Athersys (ATHX) Reports Publication of Data from Placebo-Controlled Clinical Trial Evaluating Mu… https://t.co/7QE3HzoVEK November 30th 2021, 1:11pm |
 |
@gcassidy718 $ATHX Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress… https://t.co/1FuR5LPXcc November 30th 2021, 1:11pm |
 |
@mehabecapital $ATHX @ 1.02 (-0.97%) : Athersys gains on publication of cell therapy study results against respiratory disorder https://t.co/UN58zumtsY November 30th 2021, 1:11pm |
 |
@MarketCurrents $ATHX - Athersys gains on publication of cell therapy study results against respiratory disorder https://t.co/S9RrcBqhcv November 30th 2021, 12:11pm |
|
@burqueVJ $ATHX Read article on Moderna CEO saying vaccines are less effective against Omicron variant. Can see the future th… https://t.co/DH2owLMmTH November 30th 2021, 12:11pm |
 |
@tojy547 RT @TopStockAlerts1: $ATHX gapping up nicely this morning. Strong watch! November 30th 2021, 12:11pm |
 |
@StocksTelegraph $ATHX shares are trading up 29.41% at $1.32 at the time of writing following the announcement from the company that… https://t.co/FuSh7rJEhm November 30th 2021, 12:11pm |
 |
@WallStreetTitan Publication of placebo controlled #ARDS study by $ATHX well timed given #Omnicron #Omicron #OmicronVariant. World n… https://t.co/yPPF8bCgQI November 30th 2021, 12:11pm |
 |
@StocksoftheDay_ $ATHX Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress… https://t.co/VUoIljHomh November 30th 2021, 12:11pm |
|
@TopStockAlerts1 $ATHX gapping up nicely this morning. Strong watch! November 30th 2021, 12:11pm |
 |
@petesart $ATHX https://t.co/T1oOlNxz15 November 30th 2021, 12:11pm |
 |
@Rickpilk $ATHX soaking. Popped above EMA. Should test Previous high of day. Lets go! November 30th 2021, 11:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?